Kapvay is indicated for use as add-on therapy to stimulate medications. This formulation of clonidine is indicated for treating patients with ADHD, either as monotherapy or as adjunctive therapy to ...
Medication isn’t the only option for ADHD, but for some, it can be transformative. This piece examines how ADHD can be managed, and benefits and risks to stimulant use.
A Prescription Drug User Fee Act target date of May 31, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback